Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer have?
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer has 301 citations in the OpenAlex counts ScholarIQ stores.
When was Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer published?
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer has 2023 year in the ScholarIQ index.
What is the open-access status of Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer?
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer has closed oa status in the ScholarIQ index.
What is the DOI of Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer?
The DOI for Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer is on the source record.
What is the PMID of Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer?
The PMID for Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer is on the source record.
What is the OpenAlex record for Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer?
The OpenAlex for Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer is on the source record.